Collision-induced dissociation (CID) experiments on the protonated carnosine-oxaliplatin complex, [ 
Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal's standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.
Accepted Manuscript

Dalton Transactions
www.rsc.org/dalton 
Introduction
The endogenous dipeptide L-carnosine (β-alanyl-L-histidine) [1] [2] [3] is found in different body organs such as the stomach, kidney and at elevated levels in skeletal and cardiac muscles as well as in brain tissue in olfactory bulb and hippocampus. [4, 5] Owing to its water solubility, carnosine levels are found to be particularly elevated in cytosolic cellular fractions. [6] Since its discovery there have been many investigations of its biological functions. It is now known, for example, that carnosine is able to interact with aldehydes generated inside the body as a result of glycation reactions which occur between reducing sugar and different body proteins. [7] [8] [9] This helps in protecting body proteins, giving carnosine its anti-glycating effect [7] [8] [9] which in turn can help in minimizing the effects of some diseases such as diabetes and Alzheimer. [10] Carnosine also has significant anti-inflammatory, antihypertensive, antiaging, neurological and wound healing effects [11] in addition to possessing unique antioxidant properties due to its ability to interact with highly reactive species, such as hydroxyl, super oxide and molecular oxygen free radicals, especially in the water rich environment inside the body. These antioxidant properties are prominent in the ability of carnosine to hinder lipid peroxidation, which helps in preserving the integrity of body membranes. Carnosine is also known for its buffering capability, being able to buffer the increased acidity generated by lactic acid formation inside muscle tissue during muscle stress. [12] It is also reported that carnosine can act as an effective heavy metal ion chelator able to interact with the circulating metals ions within the body such as iron, calcium, metal containing enzymes and especially copper and zinc. [13] These metal chelating properties make carnosine an effective agent in the prevention and partial reversal of cataracts [14] and in the treatment of Wilsons disease [15] and
Alzheimers. The ability of carnosine to bind Zn 2+ has been found to help modulating neuronal excitability by preventing the Zn 2+ inhibition of neurotransmitter receptors. [16] In fact polaprezinc, a commercially available carnosine-zinc(II) drug complex is marketed for its effective antiulcer properties and the ability to improve gastric health. [17] [18] [19] Additionally, it has been shown that carnosine acts as a neuroprotector [20, 21] and can retard tumour growth in mouse models. [22] More recently, it has been reported that carnosine can prevent cell proliferation in colon cancer cells. [23, 24] However, very recently it has been
shown that carnosine may be involved in complexation with and sequestering of platinum anti-cancer drugs. Specifically in vitro studies on hepatocellular carcinoma HepG2 cells have
shown that carnosine may inhibit the cytotoxic action of the third generation chemotherapeutic drug, oxaliplatin, most likely through the formation of complexes that are less cytotoxic than oxaliplatin alone. [25] Mass spectrometry has proven to be an invaluable technique in studying the interactions between anticancer platinum containing metallodrugs and biomolecules including DNA, proteins and peptides on a molecular level (for recent reviews see references 26 and 27) This is especially important as understanding these interactions allows for a better informed design of future drugs. Studies of anticancer platinum metallodrugs interactions with DNA have been most prevalent as DNA is considered the ultimate pharmacological target for such drugs. [28] [29] [30] However, more recently other targets such as proteins and peptides that often play a role in the toxicological profile of platinum anticancer drugs have been considered.
Recent examples include the successful use of Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) with electron capture detection (ECD) to identify the binding sites of cisplatin to several proteins and peptides. [31] In that study, side chain losses from the charge-reduced platinum species provided characteristic indicators for the localization of the Pt-binding sites to certain amino acid residues. [31] In other studies inductively coupled plasma mass spectrometry (ICP-MS) was employed in studying cisplatin binding to the model protein cytochrome C which is a relatively small and well-characterized protein [32] as well as to plasma proteins being among the major metabolic pathways of this metallodrug. [33] Coupling capillary electrophoresis to ICP-MS, on the other hand, allowed for examining the interaction of different candidate platinum anticancer drugs with human serum anbumin (HSA) including measurements of the kinetics of binding and the determination of number of drug molecules attached to HSA. [34] A similar study where the identification of products formed upon the binding of cisplatin, carboplatin and oxaliplatin with proteins like β-lactoglobulin, HSA and hemoglobin was examined employed Liquid chromatography electrospray ionization time of flight mass spectrometry (LC-ESI-TOF-MS). [35] Finally, electrospray ionization with tandem mass spectrometry (ESI-MS/MS) was employed to probe structural information and examine dissociation pathways for the main reaction products of cisplatin with several sulphur containing peptides. [36] Specifically a study on the interactions of oxaliplatin with carnosine as well as two of its derivatives β-alanyl-N-methylhistidine (anserine) and N-acetylcarnosine (NAC) was recently reported employing various mass spectrometric techniques utilizing electrospray ionization and chip nanospray. [25] In that study a detailed characterization of the protonated complexes of oxaliplatin with each of these three dipeptide ligands as well as their collision induced fragments have been presented. [25] In the present paper, an analysis of the potential energy surfaces (PESs) for the gas phase dissociation of the protonated carnosine-oxaliplatin complex is presented. A comparison between the calculated potential energy surfaces of the dissociation process and the energy resolved collision induced dissociation of the protonated carnosine-oxaliplatin complex is also reported.
Instrumentation
A tandem quadrupole mass spectrometer, An Acquity TQ (Waters, MA, USA) equipped with electrospray ionisation interface was used in this work. The instrument was operated in positive ion mode, with typical values of cone and extractor voltages set to 30, and 3
respectively. The capillary voltage was optimised day to day for maximum signal transmission and spray stability, the optimised range was typically 2200-2500 volts. The desolvation gas was usually set at a flow of 250 L h −1 and a temperature of 150 ºC. Argon was used as the collision gas at a typical flow rate of 0.15 ml min -1 . Ions sampled from the electrospray suffered many collisions in an attempt to achieve effective thermalization in the lens region, being from the orifice/skimmer to the first r.f. only quadrupole. The bias potential in this lens region was set up to strike a compromise between signal transmission and minimal collisional heating. The precursor ions underwent multiple collisions with argon to produce tandem mass spectra obtained at collision energies in the range 0-25 eV in the lab frame having both Q1 and Q3 operated at unit resolution with typical a dwell time of 25 millisecond per transition.
Reagents
Carnosine, HPLC-grade water and methanol were all purchased from Sigma-Aldrich, UK while oxaliplatin was obtained from Sanofi-Synthelabo Limited, UK.
Computational methods
Geometry optimizations without symmetry constraints as well as frequency calculations for all the reactants, intermediates, products and transition states were performed at the Density Functional level of theory by using the hybrid exchange-correlation B3LYP functional [37] [38] [39] [40] as implemented in GAUSSIAN03 [41] code. For all the atoms the LANL2DZ [42] [43] [44] basis sets were employed. The recent successful use of the LANL2DZ basis set is proved by the calculation of both structural details of gold based drug complexes with cysteine and selenocysteine [45] and geometrical features and thermodynamic properties of Cd 2+ complexes with GSH. [46] The same basis set was used to gain insight into the decomposition pathways of photo-activated Pt containing anticancer complexes [47] and to obtain excellent agreement with experimental Raman and IR data of Pt-carboplatin complexes. [48] The use of the B3LYP/LANL2DZ computational protocol in investigating transition metal containing compounds is well established. [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] In fact, it was recently used to successfully investigate the structures of the anti-arthritic drug auranofin and its complexes with cysteine; [45] to model CO adsorption on Pt nanoclusters; [62] to obtain structural information and binding energies for the complexation of cis-and trans-Pt(NH 3 ) 2 Cl + to guanine; [57] to investigate monomeric complexes between cisplatin and glutathione; [63] to obtain excellent agreement with X-ray data for cisplatin analogues [64] and oxaliplatin analogues [65] ; as well as to examine the mechanism of Pt and Pd catalysed coupling and cyclopropanation reactions between olefins. [66] Most recently, this level of theory was used to study the interactions of the anticancer Pt containing drug oxaliplatin with each of the cytoplasmic thiol containing tripeptide ligands γ-L-glutamyl-L-cysteinyl-glycine (GSH) [67] as well as the biologically active β-alanine-L-histidine dipeptide carnosine. [25] In another recent study this level of theory has been employed to study the binding modes and binding energies of carnosine to various biologically relevant metal cations as well as to some Pt based anticancer drugs. In that study exhibited relatively small deviation. [68] In addition, the bond dissociation energy of the Pt + -CH 2 bond was also calculated at five different levels of theory and results were shown to exhibit very small variations. [68] More importantly, results were all, with the exception of the value calculated at the B3P86/LANL2DZ level of theory, shown to be within 2.3 kcal mol -1 of the experimentally determined value. [68, 69] For each optimized stationary point vibrational analysis was performed to establish its nature either as a minimum (no imaginary frequency) or a first order saddle point (one imaginary frequency). The vibrational mode associated to the imaginary frequency of each intercepted transition state was shown to correspond to the correct movement of the involved atoms. In addition, the intrinsic reaction coordinate (IRC) [70, 71] method was used to show that each located transition state is properly connected to its respective reactants and products along the imaginary mode of vibration. Calculated total electronic energies, zero-point energies, thermal corrections and entropies for all stationary points are given in Supplementary Tables   S1-S4 .
Results and discussion
Electrospraying a 2:1 mM solution mixture of carnosine with oxaliplatin in 1:1 (v/v) watermethanol solvent system generated the mass spectra shown and assigned in the top panel of Pt confirms that there is no difference in fragmentation pathways among the three platinum isotopes but most importantly allows for a quick identification of the product ions which contain the platinum metal. The product ions observed as labelled in Figure 1 and their precursor ion [Carnosine + OxPt + H] + were all previously reported and identified. [25] The energy-resolved CID spectra shown in Figure 2 reveals was previously shown to be the global minimum on this potential energy surface. [25] Structure 1A involves Pt coordination to the pros nitrogen atom of the histidine ring of that of arginine and only slightly lower than that of lysine. [60] The lowest energy conformer of the Ag + -histidine complex in that previous study also showed Pt-coordination to the pros nitrogen atoms of the histidine ring. [60] Structure 1A, as shown in Figures 7-9 and Schemes 1-3, is stabilised by three strong hydrogen bonds in addition to the one to the terminal amino nitrogen of the carnosine dipeptides. The number and, more importantly, the strength of these hydrogen bonds, with the longest being 1.886 Å, make structure 1A to be a relatively rigid conformer. This is evident in the fact that 1A structure was calculated here to have the lowest entropy value of all conformers of [carnosine + OxPt + H] + (See Tables S1-S4 ). This is in line with a previous study that showed structure 1A to have the second lowest calculated entropy value of twenty five conformers of this complex. [25] The initial step in the first path proposed for the loss of here the proton retained by the carbonyl oxygen atom does not move from its initial position, as shown in structure TS (1A→1D) in Figure 8 and Scheme 2. This transition state is only 11.1 kcal mol -1 higher in free energy relative to the starting structure 1A and leads, as shown in Figure 8 , to formation of structure 1D, which being internally stabilised by four hydrogen bonds, is higher in free energy relative to structure 1A by only 3.1 kcal mol -1 . Two simple rotations about the H-O and C-C bonds in the oxalate moiety convert structure 1D into 1E through the transition state TS (1D→1E), whose structure is shown in Figure 8 and Scheme 2, Figure 8 and Scheme 2. This transition state for the elimination of CO 2 involves a free energy barrier of 74.1 kcal mol -1 relative to the starting point structure 1E. This barrier for the elimination of CO 2 is 2.9 kcal mol -1 higher in energy than that shown in Figure 3 , which details mechanism 1. However, it involves the transition state TS (1E→2C), shown in Figure 8 and Scheme 2, which is 6.4 kcal mol -1 lower in energy relative to reference energy of the starting structure 1A on the free energy scale. Like in mechanism 1, here, the transition state TS (1E→2C) leads to the minimum structure 2C for the ion [Carnosine + OxPt -CO 2 + H] + in which the newly formed HCOO group is attached to the Pt centre through a carbonyl oxygen atom and the CO 2 molecule is now formally eliminated. This eliminated CO 2 molecule is shown in structure 2C in Figure 8 and Scheme 2 to be held by a very weak hydrogen bond at a distance of 2.289 Å to the hydrogen atom retained by the HCOO group. Removing the eliminated CO 2 molecule and allowing for simple rotations about single bonds produces the same conformer 2B as in mechanism 1 (see Figure 8 and Scheme 2), which together with CO 2 is 2.1 kcal mol -1 lower in free energy relative to 2C. The remainder of the path of mechanism 2, involving the elimination of HCOOH and NH 3 groups is identical to that described previously in mechanism 1. , respectively above the 1A global minimum. This is, however, not consistent with the energy-resolved CID data shown in Figure 2 which indicates that the ion [Carnosine -H + Pt(dach)] + is easily produced at low collision energies.
This inconsistency led us to investigate a mechanism in which the starting structure 1A is interconverted to 1D through the transition state labelled TS (1A→1D) in the same fashion as in mechanism 2 previously described. Nevertheless, structure 1D shown in Figure 9 and Scheme 3 in this case undergoes a transformation in which the Pt-O bond connecting the Pt metal to the oxalate moiety is broken and replaced by a Pt bond to the carbonyl oxygen atom of the carnosine dipeptide as shown in structure 1F in Figure 9 and Scheme 3. This leaves the oxalate moiety to form a 1.572 Å hydrogen bond through one of its carbonyl oxygen atoms to one of the hydrogen atoms of the amino groups of the dach ligand and another 1.540 Å hydrogen bond through its oxygen atom of its OH group to the hydrogen atom of the OH group the carnosine peptide. This transformation to produce structure 1F is shown to go through the transition state TS (1D→1F) , which is calculated to be 31.9 kcal mol -1 in free energy higher than structure 1A as shown in Figure 5 . Structure 1F undergoes a simple rotation about a single bond involving a free energy barrier of only 6 kcal mol -1 in order to produce structure 1G in which the OH hydrogen of the oxalate moiety is on the "inside" while both hydrogen bonds to the oxalate moiety are retained. This resulting structure 1G (see Figure 9 and 
Production of [OxPt + H] + and [Carnosine + H] +
The energy-resolved CID data shown in Figure 2 calculated to be 42.0 and 52.5 kcal mol -1 in free energy higher than structure 1A, respectively. These relatively low barriers are consistent with the relative ease of production of these two ions experimentally. The relative free energies of the barriers of TS (1D→OxPtH) and TS (1D→CarH) shown in Figure 6 also predicts the production of [OxPt + H] + to be more favoured at lower energies which is corroborated by the energy-resolved CID data shown in The calculated barriers for the generation of these two latter ion was shown to be 75.2 and 85.6 kcal mol -1 respectively. Figure 7 : Structures corresponding to the fragmentation mechanism described in Figure 4 . All structures are calculated at the B3LYP/LANL2DZ level of theory. Bond lengths are in Angstroms, relative free energies are indicated in parenthesis. Gray, red, blue and white spheres represent carbon, oxygen, nitrogen and hydrogen atoms respectively. Figure 8 : Structures corresponding to the fragmentation mechanism described in Figure 5 . Figure 9 : Structures corresponding to the fragmentation mechanism described in Figure 6 . All structures are calculated at the B3LYP/LANL2DZ level of theory. Bond lengths are in Angstroms, relative free energies are indicated in parenthesis. Gray, red, blue and white spheres represent carbon, oxygen, nitrogen and hydrogen atoms respectively.
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